Posted: 04/08/2011
Amsterdam, the Netherlands, August 4, 2011 - SynCo Bio Partners B.V., one of the leading GMP contract manufacturers of biopharmaceuticals today announced that its aseptic filling facility is again fully operational and SynCo has produced and released the first drug product batches for its clients after the expansion of the Class A zone.
Read more
Posted: 11/05/2011
Amsterdam, the Netherlands, May 11, 2011 - SynCo Bio Partners B.V., one of the leading GMP contract manufacturers of biopharmaceuticals, announced today that it has signed an agreement with Syntaxin to produce its novel drug candidate SXN101959.
Read more